Table 1 Mean and SD of patients’ demographic and clinical baseline characteristics and their correlations with CDSS total scores at baseline (n = 198) and 12-month follow-up (n = 127)
From: Depressive symptoms in first episode psychosis: a one-year follow-up study
Mean (SD) | Correlation With CDSS total score at baseline (Pearson) | Correlation with CDSS total score at12-month follow-up (Pearson) | |
|---|---|---|---|
Age | 27.98 (8.70) | 0.01 | 0.10 |
Gender (M) | N = 127 (64%) | 0.18* | 0.13 |
Education (year) | 12.71 (2.93) | −0.02 | −0.13 |
GAF symptom | 41.12 (11.38) | −0.29** | −0.26** |
GAF function | 44.14 (12.65) | −0.11 | −0.22* |
PANSS positive | 12.95 (4.49) | 0.07 | 0.06 |
PANSS negative | 20.13 (7.72) | 0.11 | 0.18* |
PANSS excitative | 8.07 (2.84) | 0.21* | −0.04 |
PANSS depressive | 12.15 (3.61) | 0.58** | 0.37** |
PANSS cognitive | 5.38 (2.07) | −0.004 | 0.06 |
PANSS-total score | 63.38 (15.00) | 0.27** | 0.23* |
PAS childhood social | 2.51 (3.05) | 0.26** | 0.32** |
PAS childhood academic | 3.45 (2.43) | 0.26** | 0.26** |
PAS early adolescence social | 2.69 (2.88) | 0.21** | 0.22* |
PAS early adolesc. academic | 4.26 (2.75) | 0.24* | 0.17 |
DUPln | 1.63 (0.80) | 0.23** | 0.30** |
Insight (PANSS G12) | 2.76 (1.36) | −0.18* | −0.11 |
AUDIT | 7.76 (7.70) | 0.17* | 0.09 |
DUDIT | 6.36 (9.58) | 0.10 | 0.03 |
Anti-depressive medication day dosis | 37.50 (35.75) | 0.05 | 0.03 |
Anti-psychotic medication, day dosis | 97.17 (155.88) | −0.05 | −0.07 |
CDSS total baseline | 6.23 (4.44) | -------------------- | 0.48** |